Cargando…
Patientensicherheit in der Rheumatherapie: Labormonitoring bei Methotrexat
BACKGROUND: Methotrexate (MTX) is the most commonly prescribed disease-modifying drug in the treatment of rheumatic diseases. Regular laboratory testing is recommended to recognize side effects, such as hepatotoxicity and myelotoxicity as well as decreases in renal function that may cause toxic MTX...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Medizin
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189943/ https://www.ncbi.nlm.nih.gov/pubmed/33709166 http://dx.doi.org/10.1007/s00393-021-00976-7 |